Home ↗

Folded diary

Peptide property archive ↗

21 aa

Predicted · Cα pLDDT 92.6 / 100

Completion observed (Asia/Shanghai):

Static 3D view of the same actual atomic structure; teal-blue-lilac gradient is decorative onlyStatic 3D view of the same actual atomic structure, colored by side-chain classStatic 3D view of the same actual atomic structure, colored by prediction confidence

Static model

PAE · Å

Columns: scored residue j (1–21)
Rows: alignment residue i (1–21)Actual 21×21 PAE matrix in Å; dark green indicates lower predicted error
0 Å31.75 Å

pTM 0.15

MOLECULE PORTRAIT · EXPLORATORY RECORD

A few molecular notes beside a poem.

TIMEINGLASSSTILLSINGS

These model readings are not real-world event rates; suitability for this peptide has not been validated.

Water solubility-2.65log mol/L
Lipophilicity-0.20log-ratio
LD50 model reading3.24log(1/(mol/kg))

Modelled molecular behavior

Each endpoint keeps its own 0–1 model output; these are not cross-endpoint rankings.

Absorption & transport
Intestinal absorption · HIA
0.06
Oral bioavailability
0.27
Blood–brain barrier · BBB
0.18
P-gp
0.34
Metabolism · CYP
SubstrateInhibitionCYP2C9
0.12
0.04
CYP2D6
0.09
0.05
CYP3A4
0.72
0.02
Safety-related assays
Ames assay
0.17
Drug-induced liver injury · DILI
0.24
hERG channel
0.53
Reading notes & six additional results

Classification outputs are uncalibrated; they do not establish individual event probabilities or safety.

Method: TabPFN2.5 · tdc22_v1

Result observed at:

Chemical form: linear L-peptide, with free, neutral termini and side chains.

Units and numerical scales for these six endpoints remain unconfirmed; the model readings are retained below.

Caco-2
-7.26
Hepatocyte clearance
18.23
Microsomal clearance
43.17
Half-life
8.09
Plasma protein binding
72.07
Distribution volume
0.42

Readings retain the scale returned for each endpoint; no conversion to linear physical quantities has been made. Glyphs identify endpoints, not measurement axes.